Weight loss results vary for every individual, but clinical trials provide a clear picture of the potential outcomes when these medications are combined with lifestyle changes.
Use this guide to:
Compare average weight loss results between Mounjaro and Wegovy.
Understand the factors that influence your progress.
Set healthy, realistic weight loss goals.
Weight loss results in clinical trials
Clinical studies have shown significant weight reduction over a period of 15 to 18 months:
Mounjaro (tirzepatide): Patients lost up to 20.9% of their body weight after 72 weeks of treatment.
Wegovy (semaglutide): Patients lost an average of 14.9% of their body weight after 68 weeks.
These figures represent averages found in clinical settings; while some people lost more, others lost less.
Factors influencing your success
Medication is a powerful tool, but your individual results can also depend on several lifestyle factors:
Diet: Following a balanced, reduced-calorie nutrition plan.
Physical Activity: Incorporating regular exercise into your weekly routine.
Consistency: Adhering strictly to your weekly dosing schedule.
Setting realistic expectations
It is important to set healthy expectations based on your personal health goals. In the clinical community, it is generally recommended to aim for a steady weight loss of 1-2 lbs (0.5-1 kg) each week. This gradual pace is often more sustainable and better for long-term health.
Need further support?
If you still need help after reviewing the information above, additional assistance is available.